• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

How to Compare Conditioning Performance When Moving a Formula to a New Factory

Moving a conditioner to a new factory is rarely an ingredient-list problem. It is a measurement and process problem. Two sites can run the same formula and produce products that feel different in the…

Category: Hair Care Sourcing Guides • Author: laeyo • Published: 2026-10-31 • Views: 72

Moving a conditioner to a new factory is rarely an ingredient-list problem. It is a measurement and process problem. Two sites can run the same formula and produce products that feel different in the shower — one slippery and easy to detangle, the other waxy, grippy, or heavy — because the conditioning effect is created by a structure (the lamellar gel network formed by fatty alcohols and cationic surfactants), not by a single ingredient on the INCI list. If you are transferring a Repair Conditioner, Repair Mask, or Leave-in where the consumer-visible promise is “easier combing” or “less breakage”, you need to compare performance with the same protocol, the same reference sample, and the same proxy metrics. This guide gives you the requests, the acceptance criteria, the timeline, and the failure modes to manage that comparison as a procurement project rather than a sample swap.

1. TL;DR: what actually decides a conditioning transfer

Informational only, not legal advice.

  • What triggers the risk: any site change, tank change, or raw-material grade change on a rinse-off conditioning product where the claim depends on feel or breakage. Conditioner and mask benefits such as combability, smoothness and less breakage cannot be proven by a COA alone — they are controlled through proxy metrics plus periodic performance verification, and a new site resets both.
  • Decision 1 — lock the benchmark before you make samples: agree one protocol, one laboratory, one reference sample, and one set of acceptance criteria that both the old and new product must pass.
  • Decision 2 — choose the release proxies: pH, viscosity (with spindle, speed and time after fill defined), solids, cationic raw-material grade, and a panel or instrumental check. These are the batch-to-batch controls that connect to the validated benefit.
  • Decision 3 — decide which claims must be re-substantiated: GREEN claims (conditions hair, easier combing) usually travel with market review; AMBER claims (90% agree, 48h, reduces breakage X%) need the study re-run on the new site’s material.
  • Fastest safe path: lock benchmark + proxies + raw-material grade equivalence first. Optimise fragrance level, packaging format, or secondary cost drivers only after three commercial batches are inside spec.
  • Evidence to request immediately: (1) master formula and process instructions including heating/cooling rates and mix speeds; (2) raw-material specs and suppliers for cationic surfactant, fatty alcohols, conditioning polymer, silicones, fragrance, with grade and activity level; (3) three pilot batch records with pH, viscosity, solids; (4) instrumental wet/dry combing versus your retained reference; (5) stability, micro and preservative efficacy protocols.

2. Decision tree: classify your transfer in ten lines

  • Start here: Is this a site change of the same formula with the same raw materials, or a re-development?
  • If same formula, same raw materials, same supplier grades → Tier 1 (process equivalence). Benchmark + 3 consecutive pilot batches + proxy release specs + one instrumental comparison against your reference sample.
  • If same formula but new raw-material grades or suppliers (BTMS 25 vs 50, different polymer molecular weight, different silicone emulsion) → Tier 2 (material equivalence). Add a raw-material equivalence dossier and a deposition or combing check, plus a small panel.
  • If the formula is being “cost-optimised” during the transfer → Tier 3 (new product). Treat as a development project: full instrumental study, panel study, and claims re-substantiation.
  • If the claim contains a number, a duration, or a percentage → AMBER. Re-run the HUT or instrumental study on the new batch; do not reuse the previous site’s report.
  • If the claim implies follicle mechanism, hair growth, hair-loss prevention, or scalp treatment → STOP. Resolve product classification and registration pathway before any sampling.
  • If the product carries a “clean”, “silicone-free”, or “natural” positioning → add scrutiny. Vague natural claims risk greenwashing challenge; shift to measurable performance language backed by finished-product evidence.
  • If the destination market is the EU → confirm CPSR/PIF update and notification impact for the new site before artwork is finalised.
  • If the fragrance supplier changes at any point → treat as a safety change: exposure review, allergen and warning check, tolerance re-test assessment, and safety file update.
  • Boundary cases requiring specialist counsel or extra testing: drug-boundary claims, sensitive-scalp or paediatric users, spray formats with inhalation exposure, and any product already registered in a regulated category.

3. What to ask your manufacturer: minimum evidence pack

A) Compliance, classification and filings

  • Request: a written classification memo for each destination market (cosmetic vs drug boundary), naming the exact final wording of each claim.
    Evidence: signed classification rationale plus the claim list it applies to.
    Owner: Manufacturer / regulatory.
    Acceptance criteria: one row per claim, each marked GREEN, AMBER, RED or BLACK with the routing decision, dated and version-controlled.
  • Request: confirmation of whether the new manufacturing site triggers re-notification or file update.
    Evidence: notification/registration IDs, responsible-person details, and a written impact statement.
    Owner: Manufacturer / regulatory.
    Acceptance criteria: explicit “update required / not required” statement, signed, issued before the first commercial batch.
  • Request: SDS and full composition disclosure, including fragrance allergen declaration.
    Evidence: current SDS per market format, allergen list, IFRA certificate.
    Owner: Manufacturer + fragrance supplier.
    Acceptance criteria: documents reference the same formula version as the master formula; no open allergens above the labelling threshold.

B) Testing and substantiation

  • Request: instrumental wet and dry combing study comparing the new site’s pilot batch to your retained reference sample, run in one laboratory under one protocol.
    Evidence: report with protocol ID, tress lot ID, number of tresses per cell, conditioning cycles, temperature and humidity, raw-data summary, statistical analysis, and a conclusion limited to the tested benefit.
    Owner: Lab (single lab for both products).
    Acceptance criteria: at least 10 tresses per cell, blinded and randomised, with the result expressed as equivalence to the reference within a pre-agreed margin (for example no statistically significant difference in combing force at 95% confidence).
  • Request: combing breakage (tress) study if “helps reduce breakage” appears on pack or detail page.
    Evidence: breakage report stating the mechanism tested is breakage of the hair fibre, not shedding from the follicle.
    Owner: Lab.
    Acceptance criteria: report explicitly states the tested claim wording it supports and any restrictions (for example “use per protocol, tested conditions”).
  • Request: consumer perception (HUT) study if any percentage or agreement claim is used.
    Evidence: questionnaire wording, sample size, population, comparator, timepoint, formula version.
    Owner: Lab / manufacturer.
    Acceptance criteria: exact question text and N disclosed; result reported at the study endpoint only.

C) Labelling and claims guardrails

  • Request: a claims matrix mapping every on-pack, e-commerce and advertising claim to an evidence ID and a market.
    Evidence: claims-to-evidence register with status: supported, conditionally supported, not supported.
    Owner: Buyer + manufacturer regulatory.
    Acceptance criteria: zero claims on artwork without a linked evidence ID; no BLACK-level wording (absolute safety or “cures” language) anywhere.
  • Request: review of the product name itself, not just the copy. “Repair Conditioner” implies repair and sits in AMBER territory.
    Evidence: naming assessment with a safer alternative if evidence is limited (for example damage care, or helps improve the appearance of damaged hair).
    Owner: Buyer + regulatory.
    Acceptance criteria: written sign-off on name, front-of-pack claim and detail-page copy against one evidence version.
  • Request: INCI list reconciliation against the final formula version.
    Evidence: side-by-side comparison of artwork INCI, COA INCI and master formula.
    Owner: Manufacturer.
    Acceptance criteria: 100% line-by-line match, with the checker’s name and date recorded.

D) QA, traceability and audit readiness

  • Request: three consecutive pilot or commercial batch records, including process parameters.
    Evidence: batch records showing water phase temperature, oil phase temperature, homogenisation speed and time, cooling rate, and addition temperatures.
    Owner: Manufacturer.
    Acceptance criteria: cooling rate and mix speed recorded as numbers with tolerances, not as “cool to 40°C”.
  • Request: release specification for the conditioning product with proxy metrics.
    Evidence: spec sheet with pH, viscosity (spindle, speed, temperature, time after fill), solids, appearance, odour, and any deposition indicator.
    Owner: Manufacturer.
    Acceptance criteria: every proxy has a numeric range, a method reference and a test frequency.
  • Request: change control and deviation notification process in writing.
    Evidence: change control SOP, notification timeline, named contact.
    Owner: Manufacturer.
    Acceptance criteria: buyer notified before implementation of any raw-material, supplier, process or site change, with a stated notice period.
  • Request: GMP evidence and audit report.
    Evidence: current ISO 22716 or equivalent certificate, latest internal or third-party audit summary, CAPA closure record.
    Owner: Manufacturer.
    Acceptance criteria: certificate valid on the planned production date; no open critical findings.

Evidence pack summary

  • Master formula and process instructions with heating, cooling and shear parameters.
  • Raw-material specifications, suppliers, grades and activity levels for cationic and polymer systems.
  • Three consecutive batch records with in-process and release data.
  • Release specification with numeric proxy ranges and method references.
  • Instrumental wet and dry combing report against your retained reference sample.
  • Combing breakage report if a breakage claim is used.
  • HUT questionnaire, sample size and result if a percentage claim is used.
  • Accelerated and real-time stability protocol, plus retention sample plan.
  • Preservative efficacy and micro test reports against the destination market limits.
  • Packaging compatibility report covering fill, 40°C storage, drop and label adhesion.
  • Claims matrix with evidence IDs and market flags.
  • Document index with version numbers tied to the formula version.

4. Realistic timeline: two variants

The fastest safe path is only available when the formula and raw-material grades stay identical. Everything that touches the gel network — cooling rate, shear, cationic grade, fatty alcohol ratio — must still be verified.

Phase Duration (fast / standard) Buyer action Manufacturer action Evidence output
1. Benchmark and reference lock Week 1–2 / Week 1–3 Ship a retained reference sample of the incumbent product; approve one protocol and the equivalence margin Accept the protocol; assign one lab; confirm test methods Signed protocol with test methods, tress lot requirements, n per cell, environmental conditions
2. Material equivalence Week 1–3 / Week 2–5 Approve or reject each proposed raw-material substitution in writing Submit material equivalence dossier with grade, activity, supplier and function Raw-material comparison table with COA references and technical justification
3. Pilot batches and proxy metrics Week 3–6 (2 batches) / Week 4–8 (3 batches) Review data batch by batch; do not release artwork yet Run pilot batches; test pH, viscosity, solids, appearance; retain samples Batch records plus proxy data table showing all batches inside spec
4. Instrumental and panel comparison Week 5–9 / Week 6–12 Accept or reject equivalence; request a second panel if results are borderline Run combing and breakage studies against the reference; recruit panel if needed Study report with raw data, statistics and a supported / conditionally supported / not supported conclusion
5. Packaging compatibility and stability Week 4–12 (parallel) / Week 6–16 Lock pack format and closure early; approve the compatibility protocol Fill at line speed; run 40°C upright and inverted at 4 and 8 weeks plus drop test; start accelerated stability Compatibility report, filled-pack stability data, pump or valve dose and force data
6. Label and claims review Week 6–10 / Week 8–12 Freeze copy; sign off claims matrix and INCI Reconcile artwork against formula version; confirm market-specific wording Signed artwork proof with INCI reconciliation record
7. First commercial batch and document handoff Week 10–14 / Week 14–20 Hold release until the document index is complete Produce batch one; issue COA, SDS, stability summary, retention samples Complete document index traceable to batch number and formula version

Fastest safe path — what may compress

  • Two pilot batches instead of three, only if both are inside proxy spec and at least one is compared instrumentally to the reference.
  • Stability and compatibility run in parallel with the instrumental study.
  • Existing fragrance and existing pack format retained, so no safety re-assessment and no new tooling.

Standard path — what must not compress

  • Three consecutive batches to demonstrate process control, not luck.
  • Accelerated stability data before commercial release, plus a real-time plan with retention samples.
  • Full HUT if any percentage or agreement claim is on pack.

5. Common failure modes on a conditioning transfer

1. The new product feels waxy or grippy

Symptom: consumer panel describes the new batch as heavier and less slippery than the old one, although pH and viscosity are in spec.
Root cause: the lamellar gel network formed by fatty alcohols and cationic surfactant differs because the cooling rate, homogenisation time, or fatty alcohol ratio changed between tanks.
Prevention: freeze cooling rate, shear and addition temperatures in the master batch record, and add yield stress or a spreadability check alongside viscosity.
What to request from factory (Evidence): batch record with a cooling curve and shear parameters, viscosity at 24 hours and 7 days, yield stress data, and a blinded panel comparison against the reference sample.

2. Viscosity drifts batch to batch and thins in storage

Symptom: batch 1 at 12,000 cP, batch 3 at 8,500 cP; product thins after 8 weeks at 40°C.
Root cause: different cationic grade or activity level (for example a 25% versus 50% behentrimonium grade), inconsistent raw-material supplier, or pH drift affecting the gel network.
Prevention: specify grade and activity level in the raw-material spec, and measure viscosity at a fixed time after fill with spindle, speed and temperature defined.
What to request from factory (Evidence): three-batch viscosity data table, raw-material COAs with activity level, and accelerated stability viscosity trend.

3. Performance cannot be compared because the protocols differ

Symptom: the new site reports “no significant difference” but the numbers cannot be set against your previous study.
Root cause: different tress lots, different washing cycles, different laboratory, or different humidity and temperature between the two studies.
Prevention: one protocol, one lab, and the reference sample included as a cell in every study.
What to request from factory (Evidence): protocol ID, tress lot ID, cycle count, environmental conditions, raw data, and statistical analysis.

4. Packaging compatibility failure

Symptom: pump or flip-top dispenses in uneven surges or fails to prime; label edges lift after two weeks; leakage at the cap after 40°C storage.
Root cause: viscosity and shear-thinning behaviour of the new batch do not match the pump’s dose curve; adhesive and liner are incompatible with the fragrance system or with a PCR substrate’s surface energy.
Prevention: fill at production line speed, test actuation force and dose with the final viscosity, and run 40°C upright and inverted storage plus drop test before artwork is printed.
What to request from factory (Evidence): compatibility report, pump dose and force curve at the specified viscosity, label adhesion results, and photographs of filled packs after storage.

5. Documentation failure at handoff

Symptom: COA, SDS or stability report missing at launch, or the stability report references a different formula version than the batch produced.
Root cause: no document version control tied to formula version, and no defined handoff owner.
Prevention: a signed document index with version numbers, issued before commercial release, cross-checked against the batch number.
What to request from factory (Evidence): document index listing COA, SDS, stability, micro, PET, compatibility report and claims matrix, each with version and date.

6. Fragrance or preservative change invalidates the safety file

Symptom: allergen list on pack does not match the fragrance actually used, or complaints of scalp discomfort appear after launch.
Root cause: supplier substitution made under purchasing authority without change control, so exposure and tolerance were never re-assessed.
Prevention: contractual notification before any fragrance or preservative change, with mandatory safety file update and tolerance re-test assessment.
What to request from factory (Evidence): IFRA certificate, allergen declaration, safety assessment update memo, and documented tolerance re-test decision.

7. Claims overreach on a “repair” positioning

Symptom: marketplace listing rejected, or regulatory challenge over repair, growth or treatment language.
Root cause: product name and copy imply a mechanism beyond the tested benefit, pushing a cosmetic claim toward a drug boundary.
Prevention: run every claim and the product name through a claims matrix before artwork; keep wording anchored to tested combability and breakage outcomes.
What to request from factory (Evidence): claims matrix with evidence IDs, status flags per market, and regulatory sign-off on the final wording.

8. Micro or preservation failure after the site change

Symptom: preservative efficacy test fails, or micro counts approach the limit in the first commercial batches.
Root cause: water quality, hold times, tank sanitation or bulk storage temperature differ at the new site, while the preservative system was validated against the old process.
Prevention: re-run preservative efficacy and micro testing on product from the new site, and define maximum bulk hold time.
What to request from factory (Evidence): PET report with method and acceptance criteria, micro results against destination market limits, water quality records, and bulk hold time specification.

6. Copy-paste checklist and summary table

Email-ready request list

Subject: Conditioning performance transfer pack — [Brand] x [Factory]

Share the master formula and process instructions, including heating and cooling rates and mix speeds, for the current and proposed sites.
Confirm whether this is same-formula and same-raw-material, or a re-development.
Provide specifications, suppliers and grades for the cationic surfactant, fatty alcohols, conditioning polymer, silicones and fragrance.
State the activity level of each cationic raw material and confirm the new site can source the same grade.
Attach three consecutive pilot batch records with in-process and release data.
Provide pH, viscosity (spindle, speed, temperature, time after fill) and solids for each pilot batch.
Run instrumental wet and dry combing against our retained reference sample in one laboratory.
Include tress lot ID, number of tresses per cell, humidity, temperature, wash cycles and statistical analysis.
Test combing breakage if the claim "helps reduce breakage" will be used.
Provide the stability protocol, accelerated conditions, timepoints, real-time plan and retention sample policy.
Provide the preservative efficacy method and micro acceptance criteria for the destination market.
Fill production packs at line speed with the target fill weight.
Run compatibility at 40°C upright and inverted for 4 and 8 weeks, plus a drop test.
Confirm pump or valve dose and actuation force with the final viscosity.
Attach the fragrance IFRA certificate, allergen declaration and plastic interaction notes.
Provide label artwork proof against the final formula version and INCI list.
Confirm COA, SDS and stability report all reference the same formula version.
Provide the claims matrix with an evidence ID for every on-pack and e-commerce claim.
Flag any claim implying hair growth, hair-loss prevention or scalp treatment before artwork is finalised.
Provide the GMP certificate and latest audit report with open findings status.
Confirm change control notification timelines in writing.
State the document handoff date for the first commercial batch.

Summary table: levers, red lines and evidence

Lever / Decision Primary impact What to do (specific) Do NOT cut (red line) Evidence needed (request) Expected timeline effect
Benchmark protocol Makes old and new data comparable Fix one lab, one protocol, one equivalence margin before any sample is made A defined statistical acceptance margin and n ≥ 10 tresses per cell Signed protocol with methods and acceptance criteria Adds 1–2 weeks up front, avoids 4–6 weeks of rework
Reference sample Anchors the comparison Ship retained incumbent product and include it as a cell in every study Reference tested in the same run, same tress lot Retention sample records with batch and age Prevents a full study repeat
Gel-network process parameters Controls feel, viscosity and stability Record cooling rate, shear and addition temperatures as numbers with tolerances Numeric cooling rate and mix speed in the batch record Batch record with cooling curve and in-process checks Adds 1 week, prevents batch-to-batch drift
Cationic and polymer grade equivalence Prevents silent performance loss Approve each substitution in writing by grade, activity level and function Supplier COA with activity level for every cationic raw material Material equivalence dossier Adds 2–3 weeks if substitutes are proposed
Instrumental combing study Substantiates combability and breakage claims Run wet and dry combing plus breakage against the reference, single lab Blinded, randomised design with raw-data summary Study report with statistics and claim conclusion 4–6 weeks; runs in parallel with stability
Panel or HUT design Supports any percentage claim Define exact question wording, population and timepoint before recruitment Disclosed N and exact questionnaire text HUT report with comparator and formula version 4–8 weeks; only needed for AMBER claims
Proxy release specifications Keeps future batches consistent Set numeric ranges for pH, viscosity, solids and odour with method references Viscosity method defined by spindle, speed, temperature and timing Release specification and three-batch data set No delay if agreed at pilot stage
Packaging compatibility Prevents leaks and dispensing complaints Fill at line speed and test dose, actuation force, 40°C inverted storage and drop 8-week real-time or 40°C compatibility data before print Compatibility report with pump curve and adhesion results 8–12 weeks; start early, run in parallel
Document and claims handoff Enables launch and audit readiness Issue a version-controlled document index tied to batch and formula version All regulatory documents referencing one formula version Document index, claims matrix, COA, SDS, stability, micro, PET 1–2 weeks; blocks release if missing

7. FAQ for buyers mid-transfer

Can we accept the new factory’s own combing data as proof?

Only if it was generated against your retained reference sample under the agreed protocol. A standalone report showing the new product performs well tells you nothing about equivalence to the product your customers already know.

Do we need a new consumer study for a site change?

It depends on claim level. Cosmetic-level wording such as conditions hair or easier combing usually needs finished-product evidence plus market review. Any number, duration, percentage or “clinically tested” style claim requires the study to be re-run on the new site’s material under stated conditions.

How many pilot batches are enough?

Three consecutive batches is the standard for demonstrating process control. Two can be acceptable on a same-formula transfer only when both are inside proxy spec and at least one is compared instrumentally to the reference.

What if a raw material is unavailable and the formula must change?

Then it is a reformulation, not a transfer. Require a material equivalence dossier, re-benchmark against the reference, and re-check any claim that depends on the changed material. Do not accept “same INCI, different supplier” as automatically equivalent.

What is a realistic end-to-end duration?

Roughly 10–14 weeks on the fastest safe path with an unchanged formula, and 14–20 weeks on the standard path once stability, compatibility and any consumer study are included. Packaging lead time is usually the constraint, not the laboratory.

Next step

If you are comparing conditioning performance across sites, start by sending your reference sample, target markets, claim list and current specification to the factory — that single package removes most of the back-and-forth. Request a Quote and include: target market(s), SKU count and formats (conditioner, mask, leave-in), brand positioning, packaging direction, and your target launch date. Quotes move faster when the claim level and the destination market are stated up front.

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).